Your browser doesn't support javascript.
loading
Immune Checkpoint Inhibitor-induced Pneumonitis: Incidence, Clinical Characteristics, and Outcomes.
Banavasi, Harsha; Kim, Seongho; Alkassis, Samer; Daoud, Asil; Laktineh, Amir; Nagasaka, Misako; Sukari, Ammar; Soubani, Ayman O.
Afiliación
  • Banavasi H; Division of Pulmonary, Critical Care and Sleep Medicine, Wayne State University School of Medicine, Detroit, MI, USA.
  • Kim S; Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA.
  • Alkassis S; Division of Pulmonary, Critical Care and Sleep Medicine, Wayne State University School of Medicine, Detroit, MI, USA.
  • Daoud A; Division of Pulmonary, Critical Care and Sleep Medicine, Wayne State University School of Medicine, Detroit, MI, USA.
  • Laktineh A; Division of Pulmonary, Critical Care and Sleep Medicine, Wayne State University School of Medicine, Detroit, MI, USA.
  • Nagasaka M; Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA.
  • Sukari A; Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA.
  • Soubani AO; Division of Pulmonary, Critical Care and Sleep Medicine, Wayne State University School of Medicine, Detroit, MI, USA.
Hematol Oncol Stem Cell Ther ; 16(2): 144-150, 2023 Jan 17.
Article en En | MEDLINE | ID: mdl-34688626
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neumonía / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Incidence_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Hematol Oncol Stem Cell Ther Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neumonía / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Incidence_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Hematol Oncol Stem Cell Ther Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos